A case of cyclosporine-induced dural sinus thrombosis [5]

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 6, 2005, Pages 1327-1328

  Al Shekhlee, Amer ^a,b   Oghlakian, G ^a   Katirji, B ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HEPARIN; MERCAPTOPURINE; PREDNISONE; WARFARIN;

ADULT; APHASIA; CASE REPORT; CEREBRAL SINUS THROMBOSIS; DISEASE COURSE; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DURA MATER SINUS THROMBOSIS; FEMALE; HEADACHE; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT WITHDRAWAL; ULCERATIVE COLITIS; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; THROMBOPHILIA;

COLITIS, ULCERATIVE; CYCLOSPORINE; FEMALE; HUMANS; MIDDLE AGED; SINUS THROMBOSIS, INTRACRANIAL; THROMBOPHILIA;

EID: 24944493338     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01387.x     Document Type: Letter

References (13)

1. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporine in ulcerative colitis: A five-year experience. Am J Gastroenterol 1999; 94: 1587-92.
2. Burke JF, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, Van Buren DH, West JC. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994; 331: 358-63.
3. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004; 99: 97-101.
4. Fishman SJ, Wylonis LJ, Glickman JD, Cook JJ, Warsaw DS, Fisher CA, Jorkasky DJ, Niewiarowski S, Addonizio VP. Cyclosporine A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability. J Surg Res 1991; 51: 93-8.
5. Bombeli T, Müller M, Werner Straub P, Haeberli A. Cyclosporine-induced detachment of vascular endothelial cells initiates the extrinsic coagulation system in plasma and whole blood. J Lab Clin Med 1996; 127: 621-34.
6. Vanrenterghem Y, Roels L, Lerut T, Gruwez J, Michielsen P, Gresele P, Deckmyn H, Colucci M, Arnout J, Vermylen J. Thromboembolic complications and haemostatic changes in cyclosporine-treated cadaveric kidney allograft recipients. Lancet 1985; 1: 999-1002.
7. Ueda D, Suzuki K, Malyszko J, Pietraszek MH, Takada Y, Takada A, Kawabe K. Fibrinolysis and serotonin under cyclosporine A treatment in renal transplant recipients. Thromb Res 1994; 76: 97-102.
8. Cohen H, Neild GH, Patel R, Mackie IJ, Machin SJ. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporine-treated renal allograft recipients. Thromb Res 1988; 49: 91-101.
9. Grip O, Svensson P, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000; 35: 619-23.
10. Bernstein C, Blanchard J, Houston D, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population based cohort study. Thromb Haemost 2001; 85: 430-4.
11. Kao A, Dlugos D, Hunter JV, Mamula P, Thorarensen O. Anti-coagulation therapy in cerebral sinovenous thrombosis and ulcerative colitis in children. J Child Neurol 2002; 17: 479-82.
12. Ozdil S, Akyuz F, Pinarbasi B, Demir K, Karaca C, Boztas G, Kaymakoglu S, Mungan Z, Besisik F, Cakaloglu Y, Okten A. Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Hepato-Gastroenterology 2004; 51: 768-70.
13. Murata S, Ishikawa N, Oshikawa S, Yamaga J, Ootsuka M, Date H, Kitani M, Inatsu H, Eto T. Cerebral sinus thrombosis associated with severe active ulcerative colitis. Intern Med 2004; 43: 400-3.